Clinical evidence : According to UpToDate, DPP-4 inhibitors can reduce A1C levels by around 0.5-0.8%
In this chapter, we discuss the influence of some of these microbial-related metabolites on host (patho)physiological processes known to be involved in the development of metabolic disorders, such as obesity and its related comorbidities
Starting your weight loss journey
doi: 10.3389/fendo.2026.1822475 Received 03 March 2026 Revised 05 May 2026 Accepted 02 June 2026 Published 18 June 2026 Volume 17 - 2026 Edited by Carmine Bruno, Link Campus University, Italy Reviewed by Matej Rakusa, University Medical Centre Ljubljana, Slovenia Fredrik Tiberg, Camurus AB, Sweden Updates Copyright 2026 Dominikowski, Rko, Olejarz, Szczepanek-Parulska, Domin and Ruchaa
Your physician will develop a comprehensive protocol tailored to your needs